Takeda Takes Home Some Injunctions In Generic Drug Battle
A Delaware federal judge has granted Takeda Pharmaceutical's request for injunctions against two generic-drug makers in its legal war to protect its grip on the antidepressants Brintellix and Trintellix, but rejected...To view the full article, register now.
Already a subscriber? Click here to view full article